L
The startup has developed a data analytics platform that utilizes bio-inspired signal processing technology to model the biology of diseases, enabling precise diagnostics and prognostics for various cancers, inflammatory diseases, and neurological disorders. This approach reduces patient suffering and mitigates risks in drug development by effectively integrating complex biomarkers, lab assessments, clinical history, and demographics.
Aliso Viejo, United States
Updated 2 months ago
Funding
$40.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup has developed a data analytics platform that utilizes bio-inspired signal processing technology to model the biology of diseases, enabling precise diagnostics and prognostics for various cancers, inflammatory diseases, and neurological disorders. This approach reduces patient suffering and mitigates risks in drug development by effectively integrating complex biomarkers, lab assessments, clinical history, and demographics.